The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use of some multiple sclerosis drugs including Teva's Copaxone.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback